These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3094590)

  • 1. [Kinetic characteristics of the activation of various structural forms of plasminogen by tissue activator in the presence of fibrin].
    Taran LD; Makagonenko EM; Nazarenko NA; Kudinov SA
    Biokhimiia; 1986 Aug; 51(8):1256-61. PubMed ID: 3094590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetics of glu- and lys-plasminogen activation by the tissue activator in a fibrin clot].
    Makogonenko EM; Kirpa SA; Lugovskoĭ EV; Nazarenko NA; Kudinov SA
    Biokhimiia; 1987 Oct; 52(10):1746-52. PubMed ID: 3122854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
    Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
    Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.
    Maekawa H; Yamazumi K; Muramatsu S; Kaneko M; Hirata H; Takahashi N; Arocha-Piñango CL; Rodriguez S; Nagy H; Perez-Requejo JL
    J Clin Invest; 1992 Jul; 90(1):67-76. PubMed ID: 1634621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of kringle 2 glycosylation in a hybrid plasminogen activator.
    Asselbergs FA; Bürgi R; van Oostrum J
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):27-33. PubMed ID: 8384498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.
    Weisel JW; Nagaswami C; Korsholm B; Petersen LC; Suenson E
    J Mol Biol; 1994 Jan; 235(3):1117-35. PubMed ID: 8289311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of potentiation of tissue-type plasminogen activator.
    Lazos SA; Wong SS
    Biochem Mol Biol Int; 1995 Dec; 37(6):1071-77. PubMed ID: 8747537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the kinetics of plasminogen activation by tissue plasminogen activator.
    Rånby M
    Biochim Biophys Acta; 1982 Jun; 704(3):461-9. PubMed ID: 6214279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activation in diabetes mellitus. Kinetics of plasmin formation with tissue plasminogen activator and plasminogen from individual diabetic donors and with in vitro glucosylated plasminogen.
    Geiger M; Binder BR
    Enzyme; 1988; 40(2-3):149-57. PubMed ID: 2971532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.
    Horrevoets AJ; Pannekoek H; Nesheim ME
    J Biol Chem; 1997 Jan; 272(4):2183-91. PubMed ID: 9036151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of t-PA on the initiation and regulation of fibrinolysis].
    Matsuo O
    Rinsho Byori; 1989 Apr; Spec No 81():99-106. PubMed ID: 2502643
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
    Hoylaerts M; Rijken DC; Lijnen HR; Collen D
    J Biol Chem; 1982 Mar; 257(6):2912-9. PubMed ID: 7199524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.